RMD Resmed Inc revenue, earnings and financials

For the quarter ended March 31, 2026, Resmed Inc reported revenue of $1.43B (up 10.8% from a year earlier), net income of $399M and diluted EPS of $2.74; over the last four quarters revenue was $5.54B and net income $1.52B; for the fiscal year ended June 2025 revenue was $5.15B, up 9.8% on the year before.

RMD annual revenue and earnings

• Fiscal year ended Jun 2025: revenue $5.15B, gross profit $3.05B, operating income $1.69B, net income $1.40B (margin 27.2%), EPS $9.51
• Fiscal year ended Jun 2024: revenue $4.69B, gross profit $2.66B, operating income $1.32B, net income $1.02B (margin 21.8%), EPS $6.92
• Fiscal year ended Jun 2023: revenue $4.22B, gross profit $2.36B, operating income $1.13B, net income $898M (margin 21.3%), EPS $6.09
• Fiscal year ended Jun 2022: revenue $3.58B, gross profit $2.02B, operating income $1.00B, net income $779M (margin 21.8%), EPS $5.30
• Fiscal year ended Jun 2021: revenue $3.20B, gross profit $1.84B, operating income $904M, net income $475M (margin 14.8%), EPS $3.24

RMD quarterly revenue and earnings

• Quarter ended Mar 31, 2026: revenue $1.43B (up 10.8% year over year), net income $399M, EPS $2.74
• Quarter ended Dec 31, 2025: revenue $1.42B (up 11.0% year over year), net income $393M, EPS $2.68
• Quarter ended Sep 30, 2025: revenue $1.34B (up 9.1% year over year), net income $349M, EPS $2.37
• Quarter ended Jun 30, 2025 (from the annual report): revenue $1.35B (up 10.2% year over year), net income $380M, EPS $2.58
• Quarter ended Mar 31, 2025: revenue $1.29B (up 7.9% year over year), net income $365M, EPS $2.48
• Quarter ended Dec 31, 2024: revenue $1.28B (up 10.3% year over year), net income $345M, EPS $2.34
• Quarter ended Sep 30, 2024: revenue $1.22B (up 11.1% year over year), net income $311M, EPS $2.11
• Quarter ended Jun 30, 2024 (from the annual report): revenue $1.22B (up 9.0% year over year), net income $292M, EPS $1.97
• Quarter ended Mar 31, 2024: revenue $1.20B (up 7.2% year over year), net income $300M, EPS $2.04
• Quarter ended Dec 31, 2023: revenue $1.16B (up 12.5% year over year), net income $209M, EPS $1.42
• Quarter ended Sep 30, 2023: revenue $1.10B (up 16.0% year over year), net income $219M, EPS $1.49
• Quarter ended Jun 30, 2023 (from the annual report): revenue $1.12B (up 22.7% year over year), net income $230M, EPS $1.55
• Quarter ended Mar 31, 2023: revenue $1.12B (up 29.2% year over year), net income $233M, EPS $1.58
• Quarter ended Dec 31, 2022: revenue $1.03B (up 15.5% year over year), net income $225M, EPS $1.53
• Quarter ended Sep 30, 2022: revenue $950M (up 5.1% year over year), net income $210M, EPS $1.43
• Quarter ended Jun 30, 2022 (from the annual report): revenue $915M, net income $195M, EPS $1.32
• Quarter ended Mar 31, 2022: revenue $865M (up 12.5% year over year), net income $179M, EPS $1.22
• Quarter ended Dec 31, 2021: revenue $895M, net income $202M, EPS $1.37
• Quarter ended Sep 30, 2021: revenue $904M, net income $204M, EPS $1.39
• Quarter ended Mar 31, 2021: revenue $769M, net income −$78.5M, EPS −$0.54

RMD cash flow, buybacks and dividends

• Fiscal year ended Jun 2025: operating cash flow $1.75B, share buybacks $300M, dividends $2.12 per share
• Fiscal year ended Jun 2024: operating cash flow $1.40B, share buybacks $150M, dividends $1.92 per share
• Fiscal year ended Jun 2023: operating cash flow $693M, share buybacks $0, dividends $1.76 per share
• Fiscal year ended Jun 2022: operating cash flow $351M, share buybacks $0, dividends $1.68 per share
• Fiscal year ended Jun 2021: operating cash flow $737M, share buybacks n/a, dividends $1.56 per share

RMD balance sheet

• Jun 30, 2026: cash $1.47B, total assets $8.97B, total liabilities $2.38B, shareholders' equity $6.59B
• Mar 31, 2026: cash $1.66B, total assets $8.78B, total liabilities $2.29B, shareholders' equity $6.49B
• Dec 31, 2025: cash $1.42B, total assets $8.50B, total liabilities $2.18B, shareholders' equity $6.32B
• Sep 30, 2025: cash $1.38B, total assets $8.31B, total liabilities $2.19B, shareholders' equity $6.12B
• Jun 30, 2025: cash $1.21B, total assets $8.17B, total liabilities $2.21B, shareholders' equity $5.97B
• Mar 31, 2025: cash $933M, total assets $7.57B, total liabilities $2.02B, shareholders' equity $5.55B
• Dec 31, 2024: cash $522M, total assets $7.14B, total liabilities $1.89B, shareholders' equity $5.25B
• Sep 30, 2024: cash $426M, total assets $7.22B, total liabilities $2.03B, shareholders' equity $5.20B

What is RMD's revenue?

Resmed Inc reported $5.54B of revenue over its last four quarters, through March 31, 2026.

Is RMD profitable?

Yes. Resmed Inc earned $1.52B over the last four quarters.

What is RMD's EPS?

Diluted earnings per share over the last four quarters were $10.37; $2.74 in the latest quarter.

Does RMD pay a dividend?

Resmed Inc paid $2.12 per share in dividends in the fiscal year ended June 2025.

RMD ownership and insider trades · All stocks